Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1080

Bifidobacterium breve strain KCTC 12201BP

Intended Use: Intended for use as an ingredient at a level up to 109 colony forming units (CFU)/serving in liquid unflavored milk, excluding use in infant formula, food products intended for infants and young children, and any products under the jurisdiction of the U.S. Department of Agriculture.
Basis: Scientific procedures
Notifier: Rejimus, Inc.
Notifier Address: 600 W. Santa Ana Blvd.
Suite 1100
Santa Ana, CA 92701
GRAS Notice (releasable information): GRN 1080 with amendments (in PDF) (7.7 MB)
Date of closure: Oct 31, 2023
FDA's Letter: FDA has no questions (in PDF) (241 kB)
-
-